Benedict Financial Advisors Inc
Source: SEC Form 13F · as of Mar 2026Benedict Financial Advisors Inc holds 13 biotech & pharma companies tracked by BioSniper, totaling $69.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$69.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 61,381 | $15.0M |
| AMGNAMGEN INC | 33,284 | $11.7M |
| PMPhilip Morris International Inc | 69,847 | $11.5M |
| ABBVAbbVie Inc. | 46,529 | $10.1M |
| CORCencora Inc. | 16,014 | $5.0M |
| BMYBRISTOL MYERS SQUIBB CO | 69,186 | $4.2M |
| ABTABBOTT LABORATORIES | 32,695 | $3.4M |
| NVSNovartis AG | 17,366 | $2.7M |
| ELVElevance Health Inc. | 8,705 | $2.5M |
| GILDGILEAD SCIENCES, INC. | 11,784 | $1.6M |
| NVONovo Nordisk A/S | 33,489 | $1.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 821 | $222K |
| GANXGain Therapeutics, Inc. | 15,500 | $30K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.